Yale-New Haven Medical Center Cardiovascular Disease

Topics

• Cardiac Imaging and Diagnostics 942
• Coronary Interventions and Diagnostics 835
• Cardiac Valve Diseases and Treatments 665
• Heart Failure Treatment and Management 654
• Acute Myocardial Infarction Research 620
• Atrial Fibrillation Management and Outcomes 480
• Cardiac pacing and defibrillation studies 412
• Diabetes Treatment and Management 361
• Lipoproteins and Cardiovascular Health 302
• Peripheral Artery Disease Management 295
• Cardiovascular Function and Risk Factors 262
• Mechanical Circulatory Support Devices 239

Most cited

1. Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association.

   Circulation · 2023 · 1,648 citations · Mikhail Kosiborod

2. Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction.

   The New England journal of medicine · 2022 · 2,297 citations · Mikhail Kosiborod

3. Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity.

   The New England journal of medicine · 2023 · 1,343 citations · Mikhail Kosiborod

4. 2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation.

   Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024 · 619 citations · James Freeman

5. A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association.

   Circulation · 2023 · 1,080 citations · Mikhail Kosiborod

6. Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction.